MRSN – mersana therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Why Analysts See Mersana's Story Shifting To Deal And CVR Outcomes After $1B Buyout [Yahoo! Finance]
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana Therapeutics, Inc. (Nasdaq - MRSN), Cidara Therapeutics, Inc. (Nasdaq - CDTX), Cadence Bank (NYSE – CADE)
Form SC 14D9 Mersana Therapeutics, Filed by: Mersana Therapeutics, Inc.
Form SC TO-T Mersana Therapeutics, Filed by: Day One Biopharmaceuticals, Inc.
Form SC TO-C Mersana Therapeutics, Filed by: Day One Biopharmaceuticals, Inc.
Form SCHEDULE 13G Mersana Therapeutics, Filed by: 683 Capital Management, LLC
Form SCHEDULE 13G Mersana Therapeutics, Filed by: Schonfeld Strategic Advisors LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.